Skip to content
Recall Observatory FDA recall evidence

Device product

Coronavirus antigen detection test system - Product Usage: intended for the qualitative detection of the nucleocapsid protein antigen to SARS-CoV-2 directly from nasal swab samples collected from individuals suspected of COVID-19 by their healthcare provider within the first twelve days of symptom onset.

Z-1312-2021

February 03, 2021

Class II

Product summary

Firm
LumiraDx
Event
Event 87366
Status
Terminated
Classification
Class II
Quantity
2186 devices
Official record key
device-enforcement:Z-1312-2021

Official wording

Reason: Two lots of test strips failed QC testing using blank buffer due to false positives.

Code information: catalog #: L001000330001

Distribution pattern: US nationwide distribution.

Derived failure modes

  • Unknown

    reason.no_named_rule · v1.0.0

    Two lots of test strips failed QC testing using blank buffer due to false positives.